{"id":4034,"date":"2023-10-20T12:00:38","date_gmt":"2023-10-20T09:00:38","guid":{"rendered":"https:\/\/staging.iasispharma.com\/en\/?p=4034"},"modified":"2026-10-30T13:29:45","modified_gmt":"2026-10-30T11:29:45","slug":"iasis-pharma-participation-in-the-44th-panhellenic-congress-of-cardiology","status":"publish","type":"post","link":"https:\/\/iasispharma.com\/en\/all-articles\/iasis-pharma-participation-in-the-44th-panhellenic-congress-of-cardiology\/","title":{"rendered":"IASIS PHARMA PARTICIPATION IN THE: \u201c44th PANHELLENIC CONGRESS OF CARDIOLOGY \u201d"},"content":{"rendered":"<p><strong>12 \u2013 14\/10\/2023<\/strong><\/p>\n<p><strong>Thessaloniki Concert Hall<\/strong><\/p>\n<p><strong>IASIS PHARMA<\/strong> participated in the <strong>\u201c44th PANHELLENIC CONGRESS OF CARDIOLOGY\u201d<\/strong> which held on <strong>October 12-14, 2023,<\/strong> at <strong>Thessaloniki Concert Hall<\/strong>.<\/p>\n<p>The conference was organized by the <strong>Hellenic Society of Cardiology (HSC).<\/strong><\/p>\n<p>The <strong>Panhellenic Congress of Cardiology<\/strong> has established among Cardiologists and the Pharmaceutical Industry, as the Scientific Conference par excellence, with the largest participation of renowned Greek Scientists (Speakers, Presidents), high level of submitted abstracts and published poster presentations.<\/p>\n<p><strong>IASIS PHARMA<\/strong> presented at its exhibition stand the products:<\/p>\n<ul>\n<li><strong>\u00a0Rami<\/strong><strong>&#8211;<\/strong><strong>Amlo<\/strong>\u00ae\/ Ramipril &amp; Amlodipine, the original fixed dose combination of angiotensin-converting enzyme inhibitors with calcium channel blockers. Therapeutic indication, substitution therapy in patients whose blood pressure is adequately controlled with ramipril and amlodipine simultaneously at the same dose level. (Box of 28 caps, Ramipril \/ Amlodipine: 5mg \/ 5mg, 5mg \/ 10mg, 10mg \/ 5mg, 10mg \/ 10mg).<\/li>\n<li><strong>\u00a0Rami<\/strong><strong>&#8211;<\/strong><strong>Amlo<\/strong> <strong>plus<\/strong>\u00ae\/ the original fixed dose combination of Ramipril &#8211; Amlodipine &#8211; Hydrochlorothiazide, indicated for the treatment of Hypertension. (Box of 30 caps, Ramipril \/ Amlodipine \/ Hydrochlorothiazide: 5 mg \/ 5 mg \/ 12,5 mg, 5 mg \/ 5 mg \/ 25 mg, 10 mg \/ 5 mg \/ 25 mg, 10 mg \/ 10 mg \/ 25 mg).<\/li>\n<li><strong>\u00a0Licepler<\/strong>\u00ae\/ Eplerenone: Licepler is specifically indicated for the reduction of risk of cardiovascular death in people with heart failure and left ventricular dysfunction \u226440% after a recent acute myocardial infarction, in combination with standard therapies and as treatment against hypertension. (Box of 30 tabs at 25mg &amp; 50mg).<\/li>\n<li><strong>\u00a0Mag<\/strong><strong>\/<\/strong><strong>IASIS<\/strong>\u00ae\/\u00a0243 mg Magnesium, main indications: Conditions of magnesium deficiency if these cannot be treated through nutrition. Disorders of muscle function, caused by confirmed magnesium deficiency (neuromuscular disorders, muscle cramps, such as gastrocnemius cramps, nocturnal cramps). (Box of 40 eff. tabs).<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><img decoding=\"async\" class=\"alignleft wp-image-4028\" src=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2023\/10\/\u03a0\u0391\u039d\u0395\u039b\u039b-\u039a\u0394-23-STAND-1-copy.png\" alt=\"%cf%80%ce%b1%ce%bd%ce%b5%ce%bb%ce%bb-%ce%ba%ce%b4-23-stand-1-copy\" width=\"625\" height=\"559\" srcset=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2023\/10\/\u03a0\u0391\u039d\u0395\u039b\u039b-\u039a\u0394-23-STAND-1-copy-120x107.png 120w, https:\/\/iasispharma.com\/wp-content\/uploads\/2023\/10\/\u03a0\u0391\u039d\u0395\u039b\u039b-\u039a\u0394-23-STAND-1-copy-200x179.png 200w, https:\/\/iasispharma.com\/wp-content\/uploads\/2023\/10\/\u03a0\u0391\u039d\u0395\u039b\u039b-\u039a\u0394-23-STAND-1-copy-300x268.png 300w, https:\/\/iasispharma.com\/wp-content\/uploads\/2023\/10\/\u03a0\u0391\u039d\u0395\u039b\u039b-\u039a\u0394-23-STAND-1-copy-400x358.png 400w, https:\/\/iasispharma.com\/wp-content\/uploads\/2023\/10\/\u03a0\u0391\u039d\u0395\u039b\u039b-\u039a\u0394-23-STAND-1-copy-500x447.png 500w, https:\/\/iasispharma.com\/wp-content\/uploads\/2023\/10\/\u03a0\u0391\u039d\u0395\u039b\u039b-\u039a\u0394-23-STAND-1-copy-600x536.png 600w, https:\/\/iasispharma.com\/wp-content\/uploads\/2023\/10\/\u03a0\u0391\u039d\u0395\u039b\u039b-\u039a\u0394-23-STAND-1-copy-700x626.png 700w, https:\/\/iasispharma.com\/wp-content\/uploads\/2023\/10\/\u03a0\u0391\u039d\u0395\u039b\u039b-\u039a\u0394-23-STAND-1-copy-768x686.png 768w, https:\/\/iasispharma.com\/wp-content\/uploads\/2023\/10\/\u03a0\u0391\u039d\u0395\u039b\u039b-\u039a\u0394-23-STAND-1-copy.png 772w\" sizes=\"(max-width: 625px) 100vw, 625px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>12 \u2013 14\/10\/2023 Thessaloniki Concert Hall IASIS PHARMA participated in the \u201c44th PANHELLENIC CONGRESS OF CARDIOLOGY\u201d which held on October 12-14, 2023, at Thessaloniki Concert Hall. The conference was organized by the Hellenic Society of Cardiology (HSC). The Panhellenic Congress of Cardiology has established among Cardiologists and the Pharmaceutical Industry, as the Scientific Conference par  [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[33,145,157,204],"tags":[],"class_list":["post-4034","post","type-post","status-publish","format-standard","hentry","category-all-articles","category-company-news","category-press-room-en","category-conferences"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7HJeP-134","jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/4034","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/comments?post=4034"}],"version-history":[{"count":1,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/4034\/revisions"}],"predecessor-version":[{"id":4035,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/4034\/revisions\/4035"}],"wp:attachment":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/media?parent=4034"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/categories?post=4034"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/tags?post=4034"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}